| Bacteriophage targeting of gut bacterium attenuates alcoholic liver disease YI Duan, C Llorente, S Lang, K Brandl, H Chu, L Jiang, RC White, ... Nature 575 (7783), 505-511, 2019 | 603 | 2019 |
| NAFLD and cardiovascular diseases: a clinical review P Kasper, A Martin, S Lang, F Kuetting, T Goeser, M Demir, HM Steffen Clinical research in cardiology 110, 921-937, 2021 | 450 | 2021 |
| Intestinal fungal dysbiosis and systemic immune response to fungi in patients with alcoholic hepatitis S Lang, Y Duan, J Liu, MG Torralba, C Kuelbs, M Ventura‐Cots, ... Hepatology 71 (2), 522-538, 2020 | 178 | 2020 |
| The Candida albicans exotoxin candidalysin promotes alcohol-associated liver disease H Chu, Y Duan, S Lang, L Jiang, Y Wang, C Llorente, J Liu, S Mogavero, ... Journal of hepatology 72 (3), 391-400, 2020 | 151 | 2020 |
| Microbiota and fatty liver disease—the known, the unknown, and the future S Lang, B Schnabl Cell host & microbe 28 (2), 233-244, 2020 | 145 | 2020 |
| Nonalcoholic fatty liver disease–current status and future directions M Demir, S Lang, HM Steffen Journal of digestive diseases 16 (10), 541-557, 2015 | 135 | 2015 |
| Intestinal virome signature associated with severity of nonalcoholic fatty liver disease S Lang, M Demir, A Martin, LU Jiang, X Zhang, YI Duan, B Gao, ... Gastroenterology 159 (5), 1839-1852, 2020 | 132 | 2020 |
| Intestinal virome in patients with alcoholic hepatitis L Jiang, S Lang, Y Duan, X Zhang, B Gao, J Chopyk, LK Schwanemann, ... Hepatology 72 (6), 2182-2196, 2020 | 101 | 2020 |
| The fecal mycobiome in non-alcoholic fatty liver disease M Demir, S Lang, P Hartmann, Y Duan, A Martin, Y Miyamoto, ... Journal of hepatology 76 (4), 788-799, 2022 | 98 | 2022 |
| Changes in the fecal bacterial microbiota associated with disease severity in alcoholic hepatitis patients S Lang, B Fairfied, B Gao, Y Duan, X Zhang, DE Fouts, B Schnabl Gut microbes 12 (1), 1785251, 2020 | 71 | 2020 |
| Stepwise combination of simple noninvasive fibrosis scoring systems increases diagnostic accuracy in nonalcoholic fatty liver disease M Demir, S Lang, D Nierhoff, U Drebber, A Hardt, I Wedemeyer, S Schulte, ... Journal of clinical gastroenterology 47 (8), 719-726, 2013 | 55 | 2013 |
| Dynamic changes of the fungal microbiome in alcohol use disorder P Hartmann, S Lang, S Zeng, Y Duan, X Zhang, Y Wang, M Bondareva, ... Frontiers in physiology 12, 699253, 2021 | 52 | 2021 |
| Detection of clinically relevant serrated polyps during screening colonoscopy: results from seven cooperating centers within the German colorectal screening program C Schramm, K Janhsen, JH Hofer, H Toermer, A Stelzer, F Stenschke, ... Endoscopy 50 (10), 993-1000, 2018 | 43 | 2018 |
| NIKEI: a new inexpensive and non-invasive scoring system to exclude advanced fibrosis in patients with NAFLD M Demir, S Lang, M Schlattjan, U Drebber, I Wedemeyer, D Nierhoff, ... PLoS One 8 (3), e58360, 2013 | 43 | 2013 |
| High protein intake is associated with histological disease activity in patients with NAFLD S Lang, A Martin, F Farowski, H Wisplinghoff, MJGT Vehreschild, J Liu, ... Hepatology communications 4 (5), 681-695, 2020 | 42 | 2020 |
| Phenotyping non‐alcoholic fatty liver disease by the gut microbiota: ready for prime time? M Demir, S Lang, A Martin, F Farowski, H Wisplinghoff, MJGT Vehreschild, ... Journal of Gastroenterology and Hepatology 35 (11), 1969-1977, 2020 | 37 | 2020 |
| Functional microbiomics reveals alterations of the gut microbiome and host co‐metabolism in patients with alcoholic hepatitis B Gao, Y Duan, S Lang, D Barupal, TC Wu, L Valdiviez, B Roberts, ... Hepatology Communications 4 (8), 1168-1182, 2020 | 36 | 2020 |
| Serum and fecal oxylipins in patients with alcohol-related liver disease B Gao, S Lang, Y Duan, Y Wang, DL Shawcross, A Louvet, P Mathurin, ... Digestive diseases and sciences 64, 1878-1892, 2019 | 34 | 2019 |
| Management of dyslipidemia in patients with non-alcoholic fatty liver disease A Martin, S Lang, T Goeser, M Demir, HM Steffen, P Kasper Current atherosclerosis reports 24 (7), 533-546, 2022 | 33 | 2022 |
| Cytolysin‐positive Enterococcus faecalis is not increased in patients with non‐alcoholic steatohepatitis S Lang, M Demir, Y Duan, A Martin, B Schnabl Liver International 40 (4), 860-865, 2020 | 33 | 2020 |
